Drug Pipeline

IMC-001 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06365840 A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor TMB-H Recruiting
NCT04414163 A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma… Extranodal NK/T-cell Lymphoma, Nasal Type Active, Not Recruiting
NCT04196465 Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable… Subjects With Resectable and Localized Gastric Cancer Active, Not Recruiting
Sponsors Running IMC-001 Trials
Disease Areas
Get alerts when IMC-001 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free